Ángela Martínez Monleón
-
Molecular and genetic studies in high-risk
neuroblastoma
Angela Martinez-Monleon
- 2021-01-01 -
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere
maintenance
Susanne Fransson, Angela Martinez-Monleon, M. Johansson, Rose-Marie Sjöberg, C. Bjorklund, G. Ljungman, E. K. Torben, P. Kogner, Tommy Martinsson
Scientific Reports - 2020-01-01 -
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in
Neuroblastoma
Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden, Dan Emil Lind, Susanne Fransson, Angela Martinez-Monleon, Anna Djos, Rose-Marie Sjöberg, Malin Östensson, H. Caren, G. Troen, K. Beiske, A. P. Berbegall, R. Noguera, Wei-Yun Lai, P. Kogner, Ruth H. Palmer, Bengt Hallberg, Tommy Martinsson
Cell Reports - 2020-01-01 -
Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in
Neuroblastoma
N. Braekeveldt, K. von Stedingk, Susanne Fransson, Angela Martinez-Monleon, D. Lindgren, H. Axelson, F. Levander, J. Willforss, K. Hansson, I. Ora, T. Backman, A. Borjesson, S. Beckman, J. Esfandyari, A. P. Berbegall, R. Noguera, J. Karlsson, J. Koster, Tommy Martinsson, D. Gisselsson, S. Pahlman, D. Bexell
Cancer Research - 2018-01-01 -
Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAF(V600E) mutant thyroid cancer cells in 2D and 3D
culture
Camilla Ingeson-Carlsson, Angela Martinez-Monleon, Mikael Nilsson
Experimental Cell Research - 2015-01-01